Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by NOVOCURE INC.
Lobbying Relationship
Bills mentioned
H.R.4043: Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Sponsor: Suzan K. DelBene (D-Wash.)
H.R.1691: Ensuring Patient Access to Critical Breakthrough Products Act of 2023
Sponsor: Brad Wenstrup (R-Ohio)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Katherine Meyer | Sr. Policy Advisor, Office of House Republican Leader Kevin McCarthy; Deputy Health Policy Director, Senate Finance Committee; Health Policy Advisor, Senator Orrin Hatch; Sr. LA, Congressman Erik Paulsen; LA, Congressman Jeff Fortenberry Sr. Policy Advisor, Office of House Republican Leader Kevin McCarthy; Deputy Health Policy Director, Senate Finance Committee; Health Policy Advisor, Senator Orrin Hatch; Sr. LA, Congressman Erik Paulsen; LA, Congressman Jeff Fortenberry Senior Policy Advisor, Office of House Republican Leader Kevin McCarthy; Deputy Health Policy Director, Senate Finance Committee; Health Policy Advisor, Senator Orrin Hatch; Sr. LA, Congressman Erik Paulsen; LA, Congressman Jeff Fortenberry |
| Emily Haas | Senior Policy Advisor, Congressman Conor Lamb; Legislative Aide for Congresswoman Allyson Schwartz |
| Zaria Smith | n/a |
| Laura Winters | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate